Search - tctmd.com

Displaying 701 - 720 of 871

Sort: Relevancy | Date

Presentation TCT 2012

A Challenge to All Basal Modalities: Why They Can Never Be as Good as Hyperemic Indices

Presenter: Nico Pijls

October 25, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

Presentation TCT 2012

Lessons from FAME II

Presenter: Stuart Pocock

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

Presentation TCT 2012

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Presenter: William Fearon

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

Presentation TCT 2012

Case 2: FFR-Guided Decision Making for Anomalous Origin of RCA

Presenter: Bon-Kwon Koo

October 24, 2012

News Industry News

Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology

October 23, 2012

News Conference News TCT 2012

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

October 23, 2012

Presentation TCT 2012

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

Presenter: Jonathon Leipsic

October 23, 2012

Presentation TCT 2012

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

Presenter: James Min

October 23, 2012

Presentation TCT 2012

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Presenter: Tim van de Hoef

October 23, 2012

Presentation TCT 2012

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Presenter: Michael Lim

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

VERDICT/FIRST: Prospective, Multicenter Study Examining the Correlation between IVUS and FFR Parameters in Intermediate Lesions

Presenter: Gregg Stone

October 22, 2012

Presentation TCT 2012

Uses and Utility of FFR During Bifurcation Stenting

Presenter: Bon-Kwon Koo

October 22, 2012

Presentation TCT 2012

Use and Utility of FFR During Left Main Stenting

Presenter: Seung-Jung Park

October 22, 2012

Presentation TCT 2012

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

Presenter: Anupam Bhambhani

October 22, 2012

Presentation TCT 2012

RESOLVE: A Multicenter Study Evaluating the Diagnostic Accuracy of iFR Compared to FFR

Presenter: Allen Jeremias

October 22, 2012

Advertisement

A Challenge to All Basal Modalities: Why They Can Never Be as Good as Hyperemic Indices

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

Lessons from FAME II

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Case 2: FFR-Guided Decision Making for Anomalous Origin of RCA

Volcano Announces Global Launch of PrimeWire Prestige® PLUS Pressure Guide Wire with AcuSense™ Technology

VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR

The Case for CT-FFR as the Optimal Screening Tool: Latest DEScover and DeFACTO Results

TCT-19. Fractional Flow Reserved Derived from Computed Tomographic Angiography (FFRCT) for Intermediate Severity Coronary Lesions: Results from the DeFACTO Trial...

TCT-18. Long-term Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve After Deferral of Percutaneous Coronary Intervention

Physiologic Lesion Assessment: Key Clinical Results, Guidelines, and Case Presentations (with Integrated Q&A)

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

VERDICT/FIRST: Prospective, Multicenter Study Examining the Correlation between IVUS and FFR Parameters in Intermediate Lesions

Uses and Utility of FFR During Bifurcation Stenting

Use and Utility of FFR During Left Main Stenting

Role of FFR in Globally Balanced Myocardial Ischemia : Falsely Negative 99mTc Scintigram Associated with highly significant FFR

RESOLVE: A Multicenter Study Evaluating the Diagnostic Accuracy of iFR Compared to FFR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content